Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer (HERCULES)

Condition:   Penile Carcinoma Interventions:   Drug: Pembrolizumab;   Drug: Standard of care therapy Sponsors:   Latin American Cooperative Oncology Group;   Merck Sharp & Dohme Corp. Not yet recruiting

Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials